Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Filings indexed 602 across all filing types
Latest filing 2025-06-05 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 5, 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement detailing the poll results of resolutions voted on at the company’s Annual General Meeting held on June 5, 2025. It lists each resolution and the recorded votes For and Against, which is the hallmark of a ‘Declaration of Voting Results’. This falls under Filing Definition 7: Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2025-06-05 English
Terms of Reference of the Nomination Committee
Governance Information Classification · 92% confidence The document consists of the full “Terms of Reference for the Nomination Committee,” detailing committee constitution, membership, duties, authority, meeting and reporting procedures. This is a governance charter describing internal board structure and processes rather than an announcement, financial report, or other disclosure. It aligns directly with the Governance Information category.
2025-06-05 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 90% confidence The document is an announcement titled “List of Directors and Their Roles and Functions,” describing adjustments to the Board’s composition and committee memberships effective June 5, 2025. It details appointments of a non-executive director and an independent non-executive director to a Board committee, and lists Board members and their roles. This fits the definition of a Board/Management Information filing, which covers announcements of changes in the company’s board of directors or senior management.
2025-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings Classification · 85% confidence The document is a Hong Kong Exchange Listing Rules monthly return (Form FF301) disclosing movements in authorised share capital, issued shares, treasury shares, and share options for the month ended 31 May 2025. It is a routine regulatory submission rather than a full annual/interim report, earnings release, or specific corporate action notice. This falls under general regulatory filings required by the exchange and does not match any more specific category.
2025-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Share Issue/Capital Change Classification · 85% confidence The document is a statutory monthly return (Form FF301) filed to Hong Kong Exchanges (HKEX) under Listing Rule Chapter 19B, detailing movements in authorised share capital, issued shares, treasury shares, share options, and other equity transactions for the month ended 30 April 2025. It is not an earnings release, annual report, or voting announcement, nor a simple repurchase notice. Instead, it is specifically reporting share issuance and capital structure changes. This falls under the "Share Issue/Capital Change" category (SHA).
2025-05-06 English
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 5, 2025 (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for shareholders to appoint a proxy and vote at the upcoming Annual General Meeting. It contains voting instructions, resolution details, and proxy appointment procedures. This falls under “Materials sent to shareholders to provide information and request votes for meetings,” which matches the Proxy Solicitation & Information Statement category.
2025-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.